Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005–2017

BACKGROUND: Infants with congenital diaphragmatic hernia (CDH) are at an increased risk of respiratory morbidity from recurrent respiratory tract infections including those from respiratory syncytial virus (RSV). Prospective studies on RSV prophylaxis in CDH infants are limited. We determined the ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Doyoung, Saleem, Mahwesh, Paes, Bosco, Mitchell, Ian, Lanctôt, Krista L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735793/
https://www.ncbi.nlm.nih.gov/pubmed/30517603
http://dx.doi.org/10.1093/cid/ciy1010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735793/
https://www.ncbi.nlm.nih.gov/pubmed/30517603
http://dx.doi.org/10.1093/cid/ciy1010

Ejemplares similares